News

Latest news

Acticor Biotech announces the issuance of a patent in Europe for glenzocimab, its innovative product for the treatment of cardiovascular emergencies

Newton Biocapital is one of the 8 VC Firms Certified for AMED Funding Project to Boost Pharma Ecosystem

Newton Biocapitalは、国立研究開発法人日本医療研究開発機構（AMED）の令和４年度「創薬ベンチャーエコシステム強化事業」において、革新的な技術開発を行う創薬ベンチャーの支援に適した認定ベンチャーキャピタルとして採択されましたのでお知らせします。

Newton Biocapital is proud to announce that it has been certified as a part of “New Drug Discovery Venture Ecosystem Strengthening Project” by AMED (Japan Agency for Medical Research and Development).

Ambassador at Belgian Embassy of Japan and we visited PRISM BioLab Co., Ltd. together. We continue being the bridge between Japan and Europe’s best LifeSciences.

エディットフォースがCNS領域遺伝子治療で田辺三菱と導出契約、総額200億円以上

EDITFORCE AND MITSUBISHI TANABE PHARMA ENTER INTO LICENSE AGREEMENT

25th April 2022

Friendly musical evening for economic partners between Japan and Belgium

Newton Biocapital’s Successful Flagey Music & Cocktail Networking Evening

8
9
10
11
12